Technical analysis from Resmed (RMD.AX, ASX:RMD.AX) on the Australian Stock Exchange (ASX). Download the latest price data & trading signals

Resmed
+ Share

[Low Stress]: Low drawdown associated with recent trading of RMD
Ulcer Index /
[Low Stress]: Low drawdown associated with recent trading of RMD

RMD: UIX Current Signal -> (1) 17 May: Low stress (2) 16 May: Low stress (3) 15 May: Low stress

Resmed: Daily high price is $13.66 [Lower High]
High Price /
Resmed: Daily high price is $13.66 [Lower High]

[BEARISH]: Resmed current downtrend in the first timeframe. Currently, the HIGH is -0.1 %.

Volume Rate of Change /
14-day volume rate of change is now decreasing for Resmed

[BEARISH CROSSOVER]: Resmed currently has negative rate of change of -64%. This means the current volume is less than the price 14 days ago and therefore losing momentum. Currently, the return on momentum is -0.3%.

Daily Volume Index /
RMD: Current trading activity signals DVI accumulation is active

[BULLISH]: Resmed current accumulation has given strength to the share price and the continuation of bullish trading conditions. Currently, the DVI is 944.

Demarks Pivot Points /
Resmed: Look for a long limit order entry @$13.54

Resmed has broken the first DeMark resistance point ($13.5400) [Bullish]. Look for a long limit order entry near this point. Exit price for RMD should be set @$13.6 & Stoploss for Resmed should be set at $13.42

Opening Price /
[Bullish]: Opening performance for RMD of 0.3 % was achieved in last trading session

RMD: OPEN Current Signal -> (1) 17 May: BULLISH (2) 16 May: BULLISH (3) 15 May: BEARISH

Top companies for
Australian Stock Exchange
Advertisment
Close Tod Vs Close Yest /
Daily trading performance for RMD has initiated a short term downtrend

[BEARISH]: Resmedsellers are keener than buyers and are driving the price down. This is the first day of price decline for RMD adding strength to a downtrend change in the first timeframe. The biggest downward movement this month has been -0.5 & the greatest daily negative change this year has been -4.9. The longest consecutive downswing rally over the last 12 months has been 5 days giving a total rally downward movement of -7.2%. This quarter, the largest downswing rally has been 2 days giving a total rally downward movement of -2.6%. The loss ratio for price decline in the first timeframe for the last 12 months is 0.4x giving a total win/loss ratio of 1.3x. Over the last month the average daily downward movement has been -0.300000%

Limit order for a long position has been identified for Resmed [Bullish]
Woodie Pivot Point /
Limit order for a long position has been identified for Resmed [Bullish]

Resmed has broken the first Woodie resistance point ($13.63) [Bullish]. Look for a long limit order entry near this point. Exit price for RMD should be set @$13.735 & Stoploss for Resmed should be set at $13.375

Positive momentum for Resmed is a leading indicator for continued price rise
Momentum /
Positive momentum for Resmed is a leading indicator for continued price rise

[BULLISH]: Resmed currently has positive momentum of 0.23. This means the current price is greater than the price 5 days ago and therefore gaining momentum. Currently, the return on momentum is -0.3%. The largest upward momentum rally for the last 3 months is 9 days producing a return of 4.3%.

Volume /
Resmed: Daily volume performance is -14.0 [Downtrend]

[BEARISH]: Resmed current volume downtrend in the first timeframe. Volume for RMD is 1.11197e+006 (-14.0).

Ease of Movement /
Resmed Ease of Movement is -0.992 [Difficult to Move]

[BEARISH]: Resmed current price have moved downwards on high volume. Currently, the Ease of Movement is -0.992

MACD /
Resmed: MACD @0.0654 [Bullish]

[BULLISH]: Resmed currently has positive MACD of 0.0654. This means the signal line is greater than the MACD line signalling a bullish movement. Currently, the return on MACD is -0.1%.

Recent trading for Resmed fell short of the previous close by -0.3 %
Closing Price /
Recent trading for Resmed fell short of the previous close by -0.3 %

RMD: CLOSE Current Signal -> (1) 17 May: BEARISH (2) 16 May: BULLISH (3) 15 May: BEARISH

Resmed: Elder Ray Index is 0.364 [Bullish]
Elder Ray Index /
Resmed: Elder Ray Index is 0.364 [Bullish]

[BULLISH]: Resmed Elder Ray Index is signalling a Bullish movementERI is 0.364 indicating bull power. Prices are being driven above the consensus of value for RMD during the last trading session [Buying Pressure]

Aroon Oscillator /
Resmed: Aroon oscillator (48) has confirmed an uptrend is present

RMD: Aroon Oscillator Current Signal -> (1) 17 May: BULLISH (2) 17 May: BEARISH (3) 17 May: BULLISH STRONG

Average Directional Movement /
Daily trading has confirmed an ADX strong trend (26.06) for Resmed

[Trend]: ADX for RMD has confirmed a strong trend is present. Resmed has an ATR(14) of 0.17, a DX of 34.05 & an ADX(14) of 26.06

Chaikin Money Flow /
Resmed continues positive divergence & potential shift in direction

RMD: Chaikin Oscillator Current Signal -> (1) 17 May: BULLISH (2) 17 May: BULLISH CROSSOVER (3) 17 May: BEARISH CROSSOVER

14-day rate of change is increasing for Resmed
Rate of Change /
14-day rate of change is increasing for Resmed

[BULLISH]: Resmed currently has positive rate of change of 4.556%. This means the current price is greater than the price 14 days ago and therefore gaining momentum & is a leading indicator of price movement in the upward direction

Resmed has moved above the R1 Camarilla pivot point ($14.67) [Bullish]
Camarilla Pivot Points /
Resmed has moved above the R1 Camarilla pivot point ($14.67) [Bullish]

Resmed has broken the first Camarilla resistance point ($14.67) [Bullish]. Look for a long limit order entry near this point. Exit price for RMD should be set @$15.8 & Stoploss for Resmed should be set between $11.28 & $10.15

Average True Range for Resmed has signalled an uptrend is active
Average True Range /
Average True Range for Resmed has signalled an uptrend is active

[Bullish]: Average True Range has confirmed an uptrend is present. Resmed has a TR of 0.18, and an ATR(14) of 0.17.

Relative Strength Index /
Resmed is still Overbought with the Relative Strength Index @75.6

[BEARISH]: Resmed is currently Overbought highlighting the potential for a short term trend reversal in the downward direction. RSI is currently overbought @75.6

Exponential Moving Average /
[Uptrend]: Recent trading for RMD indicates ST trend is likely to continue

[BULLISH]: Resmed currently has a confirmed uptrend. Recent trading has caused the EMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on EMA5 is -0.3%.

Stochastic Oscillator /
Stochastic Overbought signal had been maintained for Resmed

[BEARISH]: Resmed is currently Overbought highlighting the potential for a short term trend reversal in the downward direction.

Elders Force Index /
Recent trading highlights continued buying pressure is present for RMD

[BULLISH]: Resmed current price has highlighted recent buying pressure. Currently, the Elders Force Index is 146456.

Resmed: Range Performance (80.0)
Range Tod Vs Range Yest /
Resmed: Range Performance (80.0)

[BEARISH]: Resmed sellers are increasingly eager. This is the first day sellers have increasing eagerness for RMD adding strength to a downtrend in the first timeframe. The biggest price range this month has been $1.1200 & the greatest daily price range this year has been $2.9000. The price range ratio this week versus the quarterly price range is 0.2x & the price range ratio this month versus the year to date price range is 0.4x.

Market movement continuation likely for RMD as a result of Fake Day
Bill Williams Market Facilitation /
Market movement continuation likely for RMD as a result of Fake Day

RMD: BWMF Recent Trading -> (1) 17 May: Fake Day (2) 16 May: Squat Day (3) 15 May: Fake Day

Long Trend /
Daily trading has maintained an Uptrend long term trend for Resmed

RMD: Long Term Trend Current Signal -> (1) 17 May: BULLISH (2) 16 May: BULLISH (3) 15 May: BULLISH

See More   See more results
Advertisment
Advertisment
back to top